In conclusion, we reassessed the biomarkers to examine the function of pancreatic beta cells in type 2 diabetes and found that C‐CPI may serve as a convenient useful biomarker for not only the requirement current insulin treatment but also the requirement of insulin therapy for 4 years. Here, INS is linked to type 2 diabetes mellitus.